Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 800–801 | Cite as

ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms

  • Yoshihide Nanno
  • Hirochika Toyama
ASO Author Reflections



All authors declare that they have no conflict of interest.


  1. 1.
    Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefGoogle Scholar
  2. 2.
    Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRefGoogle Scholar
  3. 3.
    Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.CrossRefGoogle Scholar
  4. 4.
    Nanno Y, Toyama H, Zen Y, et al. Serum elastase 1 level as a risk factor for postoperative recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasms. Ann Surg Oncol. 2018 (in press)

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Hepato-Biliary-Pancreatic SurgeryKobe University Graduate School of MedicineKobeJapan

Personalised recommendations